Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-26T23:43:21.702Z Has data issue: false hasContentIssue false

Why do children with cerebral palsy discontinue therapy with botulinum toxin A?

Published online by Cambridge University Press:  16 March 2006

Michaela Linder-Lucht
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Janbernd Kirschner
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Jochen Herrmann
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Katrin Geth
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Rudolf Korinthenberg
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Steffen Berweck
Affiliation:
Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner's Children's Hospital, University of Munich, Germany.
Florian Heinen
Affiliation:
Department of Pediatric Neurology and Developmental Medicine, Dr von Hauner's Children's Hospital, University of Munich, Germany.
Volker Mall
Affiliation:
Department of Neuropediatrics and Muscular Disorders, Children's University Hospital, Freiburg University, Germany.
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the editor
Copyright
2006 Mac Keith Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)